Showing results (1111-1120 of 30,323) with videos related to

Sort By:
Pageof 3,033
Frontiers in Pharmacology|April 28, 2025
From clinical trials to informing clinical decision-making: a review of patient-reported outcomes in nononcology medicines approved by the European Medicines Agency (2018-2022)Sarah Sauchelli, Courtney Levy, Ari Gnanasakthy, et al.
Frontiers in Pharmacology|April 28, 2025
A real-world pharmacovigilance study of adverse drug reactions associated with lecanemab and aducanumab based on WHO-VigiAccess and FAERS databasesHaoxiang Hu, Yunhan Zhao, Jiesheng Mao, et al.
Frontiers in Pharmacology|April 29, 2025
Optimization and impact of an evidence-based pre-audit prescription decision system in primary healthcare settingsXiao-Hui Yue, Lei Yang, Jing-Jing Zhong, et al.
Frontiers in Pharmacology|April 29, 2025
Corrigendum: Natural products targeting AMPK signaling pathway therapy, diabetes mellitus and its complicationsMin Li, Lu Ding, Liyuan Cao, et al.
Frontiers in Pharmacology|April 28, 2025
Corrigendum: First-time report on compound isolation from two Colocasia species: vegetable-derived bioactive metabolites and their medicinal potentialSafaet Alam, Fahmida Tasnim Richi, Nazim Uddin Emon, et al.
Frontiers in Pharmacology|April 28, 2025
The molecular determinants regulating redox signaling in diabetic endothelial cellsSwayam Prakash Srivastava, Olivia Kopasz-Gemmen, Aaron Thurman, et al.
Frontiers in Pharmacology|April 28, 2025
Social hierarchy modulates drug reinforcement and protein phosphorylation in the nucleus accumbensLiang Xu, Ruiyi Zhou, Jiafeng Zhong, et al.
Frontiers in Pharmacology|May 1, 2025
Significant hindlimb static weight-bearing asymmetry persists for 40-weeks in a longitudinal study in two widely used rat models of surgically induced osteoarthritis knee painA Kuo, A Raboczyj, J R Nicholson, et al.
Frontiers in Pharmacology|May 1, 2025
Association of long-term use of dipeptidyl peptidase-4 inhibitors with the risk of diabetic retinopathy in patients with diabetes mellitus: a real-world evidence studyYu-Ching Li, Yu-Hsiang Kuan, Yih Yang, et al.
Frontiers in Pharmacology|May 2, 2025
α-Mangostin prevents diabetic cardiomyopathy by inhibiting oxidative damage and lipotoxicity through the AKT-FOXO1-CD36 pathwayXue Bai, Ziqian Zhang, Miao Zhang, et al.
Pageof 3,033